ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,004Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 617

$658K Total Retail Price of All Prescriptions

Rank: 33 out of 617

569 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 569 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 569 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,467 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 493 358 1 3
LISINOPRIL 453 365 2 5
SIMVASTATIN 441 367 3 2
LEVOTHYROXINE SODIUM 439 362 4 1
AMLODIPINE BESYLATE 425 349 5 6
FUROSEMIDE 400 357 6 4
WARFARIN SODIUM 331 271 7 7
PRAVASTATIN SODIUM 281 232 8 21
METOPROLOL SUCCINATE 265 224 9 12
CHLORTHALIDONE 230 199 10 123
ATORVASTATIN CALCIUM 226 177 11 14
POTASSIUM CHLORIDE 210 181 12 10
CRESTOR 202 140 13 28
CITALOPRAM HBR 202 182 13 18
CARVEDILOL 189 173 15 19
HYDROCODONE-ACETAMINOPHEN 186 110 S3 16 8
HYDROCHLOROTHIAZIDE 172 135 17 13
BENAZEPRIL HCL 172 137 17 44
GABAPENTIN 169 114 19 16
METOPROLOL TARTRATE 160 149 20 11
METFORMIN HCL 158 74 21 9
FENOFIBRATE 157 151 22 58
GLIMEPIRIDE 156 135 23 33
SERTRALINE HCL 154 128 24 20
MELOXICAM 152 129 25 24
IPRATROPIUM-ALBUTEROL 145 134 26 151
RISPERIDONE 130 128 27 71
DONEPEZIL HCL 125 125 28 30
PANTOPRAZOLE SODIUM 124 94 29 37
SPIRONOLACTONE 123 99 30 42
DIOVAN 121 94 31 41
TRAMADOL HCL 119 96 32 15
ALENDRONATE SODIUM 106 93 33 25
ATENOLOL 105 93 34 17
ZOLPIDEM TARTRATE 100 69 35 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 81 36 29
RANITIDINE HCL 93 92 37 40
ROPINIROLE HCL 88 70 38 66
FLUTICASONE PROPIONATE 87 57 39 36
LOSARTAN POTASSIUM 87 87 39 22
LANTUS 79 35 41 39
CEPHALEXIN 76 69 42 68
KLOR-CON M20 70 51 43 116
CLOPIDOGREL 69 62 44 53
LANTUS SOLOSTAR 68 66 45 115
ENALAPRIL MALEATE 67 38 46 34
TAMSULOSIN HCL 65 65 47 26
NIASPAN 64 49 48 103
NAMENDA 63 63 49 35
TRICOR 63 45 49 83
POLYETHYLENE GLYCOL 3350 60 34 51 32
HUMALOG 57 29 52 152
AMIODARONE HCL 57 57 52 129
PAROXETINE HCL 56 38 54 62
CELEBREX 55 50 55 63
MIRTAZAPINE 55 54 55 50
METOLAZONE 55 42 55 159
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 44 58 91
DIGOXIN 54 40 58 48
LIPITOR 54 39 58 118
CARBIDOPA-LEVODOPA 51 43 61 69
ACTOS 51 35 61 85
BYSTOLIC 50 30 63 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.